wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q50116255-BFAF7379-C86C-4F94-8F02-79EC2B225A05
Q50116255-BFAF7379-C86C-4F94-8F02-79EC2B225A05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-BFAF7379-C86C-4F94-8F02-79EC2B225A05
Talimogene Laherparepvec: First in Class Oncolytic Virotherapy.
P2860
Q50116255-BFAF7379-C86C-4F94-8F02-79EC2B225A05
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50116255-BFAF7379-C86C-4F94-8F02-79EC2B225A05
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
b04ba680bd1fa30c74982cddf16478f7a578bdbd
P2860
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma.